Abbotsford Hospital and Cancer Centre

Name :

Abbotsford Hospital and Cancer Centre

Address  :

32900 Marshall Road

Town  :

Abbotsford

State  :

British Columbia

Country  :

CANADA

Post Code:

V2S 0C2

Phone  :

604 851 4710

Fax  :

604 851 4727

Web URL  :

Abbotsford Hospital and Cancer Centre
Specialization
  • Chemotherapy
  • Dentistry
  • Oncologist
Facilities

Description

The BC Cancer Agency is proud to announce the opening of its fifth regional cancer centre in Abbotsford which commenced care to patients on August 25th 2008

This centre is an integral link in the BC Cancer Agencys provincial services and a stateoftheart provider of cancer care and research

For residents of the Fraser Valley the opening of this centre is of enormous value offering patients the opportunity to receive a spectrum of worldclass cancer care services closer to home It expands the BC Cancer Agencys ability to pursue innovation research and improve patient outcomes

This new cancer centre is integrated within the new Abbotsford Regional Hospital and Cancer Centre site a partnership of the Fraser Health Authority and the BC Cancer Agency


The Abbotsford Centre offers a full range of cancer control services including

New patient multidisciplinary consultation and care planning
Chemotherapy and systemic care
Radiation therapy and enhanced Brachytherapy services
Supportive care and painsymptom management
Nutritional consultation and rehabilitation support
Patient and community education in cancer prevention
Access to national and international clinical trials
Professional educationliaison for community based cancer control programs
Hospitals turn to Internet to fight emergency room wait times

Patients who log on to the website for Calgarys hospitals are offered a surprising choice these days wait times for four emergency departments across the city posted automatically 247 in real time A hospital in the Southern Ontario city of Kitchener has just become the first in that province to launch its own enhanced version of the same idea am... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More